Dear AAPS members–
As you can imagine, staff and volunteers are (virtually) buzzing around in preparations for PharmSci 360 this week. The Scientific Programming Committee (SPC) held a lively check-in, going over each track and preparing for every session. Please join me in thanking this great group under the leadership of @Saileta Prabhu for the fantastic work they have done! If you are a presenter at this year's PharmSci 360, you can help us and the entire SPC sleep better by submitting your presentation recording by October 1! This is a firm deadline, so please take it seriously-we do not want to miss your science at the meeting.
I hope you have been perusing the packed schedule of the conference already, including reviewing the impressive abstract collection to decide which posters to view and authors to contact! @Teresa Homrich just added the Late Breaking Abstracts to the catalog. All the abstracts are in the online program. I like to search it by keyword, but you can browse it by author or title, too.
If you are following the latest developments in therapeutics to tackle COVID-19, I hope you had time to tune into this week's eChalk Talk by Adam Werts on Pulmonary Delivery of Test Articles by Intratracheal Nebulization or Liquid Instillation in Small Animal Models -- Implications for COVID19 Therapeutic Testing. Pulmonary delivery options for antiviral therapeutics are a hot topic! If this eChalk Talk got you interested in learning more, look no further than The AAPS Journal's most recent issue and the paper by Henrik Rasmussen and colleagues on Pulmonary Administration of Remdesivir in the Treatment of COVID-19. Reading this will help you engage in PharmSci 360-I counted 30 presentations on the program that cover all aspects of pharmaceutical development in response to COVID-19! It is a testimony to how swiftly and deeply our field is responding, but also to the dedication of our members sharing and discussing their research, which is so important for science to advance rapidly, collaboratively, and in a meaningful way.
As I continue my weekly reading, I am pleased to see that some of our most active and dedicated volunteer leaders are publishing in our journals. Check out the recent publication from @Reina Bendayan's lab on HIV-1 Sanctuary Sites-the Role of Membrane-Associated Drug Transporters and Drug Metabolic Enzymes.
In the same issue of The AAPS Journal I see another familiar name: @Leslie Benet! Yes, our organization's founder continues to lead his field. Take a look at his commentary, Investigating the Theoretical Basis for In Vitro–In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways. Les will also speak about this on November 10 during Drug Transporters 2020: Old Challenges and New Opportunities, one of the workshops that immediately follow PharmSci 360. Don't miss this opportunity to hear from a key authority in the field! Beyond the workshop, there are more than 30 presentations at the main conference on drug transporters. @Bjoern Bauer, @Steven Louie, and the very active Drug Transporter Community at AAPS hope to see you there.
As you can see, there is A LOT going on at AAPS this fall, so I hope you let our rich science at AAPS inspire you to look up and ahead.
Tina
Share your thoughts with Tina via the AAPS Community!